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Integration of retroviral DNA into host chromosomes is an essential step in the viral life 
cycle. For HIV-1 this process is mediated by integrase (IN), one of the three enzymes 
encoded in the viral genome, which catalizes two coordinated biochemical reactions 
referred to as 3’-processing and strand transfer [1]. Because IN does not have a human 
homologue, it is one of the most promising targets in AIDS research.  
In the past several years, numerous compounds with diverse structural features have been 
reported as IN inhibitors [2]. In particular a number of compounds bearing a diketo acid 
moiety (I), and more recently a class of naphthyridine carboxamide derivatives (II), were 
discovered as new selective and potent inhibitors [3].  
With the aim to identify novel and/or unified putative pharmacophore required for activity 
we selected and formally combinated the main structural motifs of I and II together to the 
hydrazide fragment of compounds III and IV, previously reported [4] as new class of 
selective IN inhibitors having antiviral activity. Also, the possibility to generate a potential 
metal chelating pharmacophore has been considered. With this in mind, we designed two 
sets of symmetrical and unsymmetrical bis-amides and hydrazide derivatives of malonic 
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Synthesis and anti-IN activities of title compounds will be presented. 
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